A Diagnostic Model for Minimal Change Disease Based on Biological Parameters
Overview
Environmental Health
General Medicine
Affiliations
Background: Minimal change disease (MCD) is a kind of nephrotic syndrome (NS). In this study, we aimed to establish a mathematical diagnostic model based on biological parameters to classify MCD.
Methods: A total of 798 NS patients were divided into MCD group and control group. The comparison of biological indicators between two groups were performed with -tests. Logistic regression was used to establish the diagnostic model, and the diagnostic value of the model was estimated using receiver operating characteristic (ROC) analysis.
Results: Thirteen indicators including Anti-phospholipase A2 receptor (anti-PLA2R) ( = 0.000), Total protein (TP) ( = 0.000), Albumin (ALB) ( = 0.000), Direct bilirubin (DB) ( = 0.002), Creatinine (Cr) ( = 0.000), Total cholesterol (CH) ( = 0.000), Lactate dehydrogenase (LDH) ( = 0.007), High density lipoprotein cholesterol (HDL) ( = 0.000), Low density lipoprotein cholesterol (LDL) ( = 0.000), Thrombin time (TT) ( = 0.000), Plasma fibrinogen (FIB) ( = 0.000), Immunoglobulin A (IgA) ( = 0.008) and Complement 3 (C3) ( = 0.019) were significantly correlated with MCD. Furthermore, the area under ROC curves of CH, HDL, LDL, TT and FIB were more than 0.70. Logistic analysis demonstrated that CH and TT were risk factors for MCD. According to the ROC of "CH+TT", the AUC was 0.827, with the sensitivity of 83.0% and the specificity of 69.8% ( = 0.000).
Conclusion: The established diagnostic model with CH and TT could be used for classified diagnosis of MCD.
Machine learning-based diagnostic prediction of minimal change disease: model development study.
Noda R, Ichikawa D, Shibagaki Y Sci Rep. 2024; 14(1):23460.
PMID: 39379539 PMC: 11461711. DOI: 10.1038/s41598-024-73898-4.
Zuo X, Bi L, Cao H Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022; 47(1):26-34.
PMID: 35545360 PMC: 10930492. DOI: 10.11817/j.issn.1672-7347.2022.201001.
Zheng Y, Zhang L, Shao P, Guo X Front Psychol. 2021; 12:726032.
PMID: 34630239 PMC: 8497756. DOI: 10.3389/fpsyg.2021.726032.
Chen S, Wang J, Liang S Am J Transl Res. 2021; 13(3):1890-1895.
PMID: 33841716 PMC: 8014369.
Prediction of steroid resistance and steroid dependence in nephrotic syndrome children.
Zaorska K, Zawierucha P, Swierczewska M, Ostalska-Nowicka D, Zachwieja J, Nowicki M J Transl Med. 2021; 19(1):130.
PMID: 33785019 PMC: 8011118. DOI: 10.1186/s12967-021-02790-w.